Skip to content

The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning

The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04957407
Enrollment
5000
Registered
2021-07-12
Start date
2019-01-01
Completion date
2022-12-31
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer, Mechine Learning, Precancerous Lesion

Brief summary

Based on the gastric cancer database established earlier, this project explored the PG standard suitable for Chinese people, and further explored the establishment of machine learning model to stratify gastric cancer risk in the population, guide the frequency of gastroscopy screening, and extract important gastric cancer risk factors from it.Establish electronic health records of gastric organs, track the development and outcome of gastric diseases through deep learning method, in order to predict the development and outcome of gastric diseases;Then, the simulation hypothesis deductive method is used to compare the outcomes that may be caused by different lifestyles with the help of deep learning model, so as to guide patients to develop a better lifestyle and explore the establishment of health management paths for gastric cancer patients and high-risk groups in China.

Interventions

diagnostic value of pepsinogen for severe atrophy and gastric cancer

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* 1) intention to undergo gastroscopy during health checkup examination; and 2) 25-75 years of age

Exclusion criteria

* 1\) a history of gastric ulcer, gastric polyp, or GC; 2) a history of gastrectomy; 3) treatment with a proton pump inhibitor in the last month; 4) contraindications to gastroscopy; 5) a history of Hp eradication; 6) a history of abdominal pain, abdominal distention, belching, acid reflux, nausea and other digestive tract symptoms within 1 month or 67) incomplete data.

Design outcomes

Primary

MeasureTime frameDescription
pepsinogen value for precanceous lesion and Gastric cancer1 yearpepsinogen value for precanceous lesion and Gastric cancer

Countries

China

Contacts

Primary ContactYuling Tong, Dr.
tongyl0313@zju.edu.cn1375821220
Backup ContactYi Zhao, Master

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026